Dr. Kaur’s research interests center on antimicrobial resistance, infectious diseases, and improving treatment strategies for difficult-to-treat bacterial infections, including pathogens recognized by the World Health Organization as major global health threats. Her work has focused on multidrug-resistant Gram-negative bacteria, particularly Klebsiella pneumoniae and Pseudomonas aeruginosa, with an emphasis on how these pathogens respond to therapy, develop resistance, and persist under drug pressure. She is especially interested in translational strategies, such as antimicrobial pharmacology, optimized combination therapy, and drug repurposing, that can enhance the effectiveness of existing and novel treatments against resistant infections.
